Boehringer Ingelheim's Board of Managing Directors | Boehringer Ingelheim
Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities.
Search
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Boehringer Ingelheim announces appointment of Vani Manja as India Country MD
Boehringer Ingelheim has announced that Vani Manja is appointed Country Managing Director for India. Read the press release here and find out more.
Speak up
We are committed to conducting business with integrity and in compliance with applicable laws, regulations, company policies and procedures. Find out more.
EFPIA disclosure
Disclosure of Boehringer Ingelheim affiliates in countries with EFPIA member associations and disclosures of transfers of value (ToVs) to HCPs and HCOs.
The Supplier Code of Conduct Download
Click here to download our supplier code of conduct. The Boehringer Ingelheim supplier code of conduct entered into force in 2016, and was updated in 2020.
COVID-19 Southeast Asia Support of Healtvare Community
Learn more about what Boehringer Ingelheim is doing to assist health workers in managing the pandemic in Southeast Asia. Click here to find out more.
The Supplier Code of Conduct
Read about Boehringer Ingelheim's expectations towards its suppliers on ethical behaviour, integrity, professionalism and common business requirements.
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Boehringer Ingelheim India and RED.Health ambulance services sign MOU to strengthen emergency stroke care in pre-hospital setup in India.
Boehringer Ingelheim India and RED.Health ambulance services sign MOU to strengthen emergency stroke care in pre-hospital setup in India.
About Us
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Click here to learn and find out more about us.
Management Systems
Suppliers shall use management systems to support continuous improvement and compliance with the supplier code of conduct. Click here to learn more.
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine. Click here to find out and learn more information.
Waste
Resource conservation at Boehringer Ingelheim is managed as part of an ongoing process of prevention and reduction of material usage and waste. Learn more.
COVID-19 Social distancing and pet care - A vet gives advice
We have asked Karsten Hesse, Technical Service Manager Pet at Boehringer Ingelheim from Germany, about the topic of social distancing and pet care.
Boehringer Ingelheim India and RED.Health ambulance services sign MOU to strengthen emergency stroke care in pre-hospital setup in India.
Collaboration marks a significant milestone in improving emergency healthcare services in the country
COVID-19 Global Access Commitment with Gates Foundation
Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing a communiqué with the Bill & Melinda Gates Foundation.
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug.
Improving Access to Stroke Care
Boehringer Ingelheim’s Angels Initiative is featured as a Best Practice example by the Access to Medicine Initiative. Click here to find out more.
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease
Jardiance® (empagliflozin) now approved in India
COVID-19 Mentally strengthened through the Corona crisis
Our individual employee consultation offers employees several support options to manage the pandemic with strengthened mental health. Learn more.
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management. Click here to find out more information.
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation
interview gregory santaner anicoon veterinaires Covid 19
Veterinarian and executive manager Grégory Santaner knows how transformative digital channels can be for the veterinary profession. Learn more here.
Afrika Kommt! - The Ripple Effect
What the Afrika Kommt! Fellowship Program means to Boehringer Ingelheim